2024

Josef Saleh is in his final year studying for a MSc degree in Pharmacy at University of Oslo. He is performing his master thesis work with the MicroPath research group from August 2024 to May 2025. Josef will work on using membrane vesicles secreted form the bacterial fish pathogen Yersinia ruckeri as a vaccine against yersiniosis in fish. He is supervised by Dr. Saranya Subramani, Dr Aashi Ramachandran, MSc Benedikte Bøe for different part of his laboratory experiments, and he is taking part in the SPARK Norway program.

Via SPARK Norway, MicroPath presented their project "Novel vaccine platform for animal health" at the Nordic Life Science days, Malmø, Swedenfrom 18th - 19th September 2024. NLS days is a two day conference on innovation in Life Sciences in the Nordics. 

For NLS conference details visit: Home - NLSDays - NLSDays

MicroPath contribute in a study exploring the co-infection of LF89 and EM90 Piscirickettsia salmonis genotypes in Atlantic salmon. The first author is the PhD student Gabriela Garill from The Norwegian University of Life Sciences. 

Please have a read at DOI: 10.1186/s13567-024-01356-0

MicroPath attended the two day seminar in the Henningsvær, Lofoten, Norway on the challenges for fish farming in Norway. The seminar included several actors within Norwegian aquaculture industry. MicroPath participation was sponsored by SPARK Norway. 

Please explore: https://www.lofotseminaret.no

MicroPath attend the ISEV conference, the annual meeting of Society of extracellular vesicles 2024. MicroPath PI Hanne C. Winther-Larsen presented a poster entitled "Recombinant extracellular vesicles as vaccines within animal health". This years meeting was hosted in Melbourne, Australia by the Australian and New Zealand Societies of extracellular vesicles. 

https://www.isev.org/isev-annual-meeting

MicroPath PhD student Rebekka Rolfsnes Hovd spent 3 months at Department of Pharmacy and Department of Chemistry, UiT: The Norwegian Arctic University. Here she conducted mechanistic studies of newly developed antimicrobial resistance breakers discovered by the biotech company AdjuTec Pharma. The research stay was sponsored by the Nordic POP research exchange program:

https://www.mn.uio.no/farmasi/forskning/nettverk/nordic-pop/

Both PhD student Rebecca Rolfsnes Hovd and PI Hanne C. Winther-Larsen attended the Nordic AMR research centre meeting in Tromsø 13th - 15th March 2024. The meeting was organized by CANS and the Network of Nordic AMR Centers. Some of the participants were lucky to observe the Northern Light after dinner events. You can check our the program at:

https://en.uit.no/tavla/artikkel/829124/nordic_amr_research_centre_meeting

Through the Norway SPARK program MicroPath PI Hanne Winther-Larsen pitched the project Novel vaccine platform for animal health at the Norway Life Science conference 2024. 

Norway Life Science 2024: Unlocking the Potential of Health Data - UiO:Life Science

We are proud and wish to congratulate Verena Mertes with her PhD. She held a fantastic trial lecture before defending her thesis in an excellent manner. 

Kasper Rømer Villumsen, Reidun Øvstebø and Rigmor Solberg acted as opponents. 

Her supervisor team was: Hanne Cecilie Winther-Larsen, Dirk Linke, Duncan Colquhoun, Elia Ciani and Athanasios Saragliadis.

Please check: Disputation: Verena Mertes - Department of Pharmacy (uio.no)